Comprehensive Evaluation of miR-15a-5p, miR-20a-5p, and miR-33b-3p Reveals EGR2-Related Biomarkers in Multiple Myeloma - Top-Institutions - MDSpire

Comprehensive Evaluation of miR-15a-5p, miR-20a-5p, and miR-33b-3p Reveals EGR2-Related Biomarkers in Multiple Myeloma

  • By

  • Riham Abdel-Hamid Haroun

  • Nada M. Ismail

  • Samar S. Elshazly

  • Fatma F. Abdel Hamid

  • Reem Nabil

  • February 12, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Molecular Biology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Genomics

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Translational Research

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Molecular Genetics

  • #5

    University of Pennsylvania (Perelman School of Medicine)
    University of Pennsylvania (Perelman School of Medicine)

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology
    • Molecular Biology

Original Source(s)

Comprehensive Evaluation of miR-15a-5p, miR-20a-5p, and miR-33b-3p Reveals EGR2-Related Biomarkers in Multiple Myeloma

  • by Riham Abdel-Hamid Haroun, Nada M. Ismail, Samar S. Elshazly, Fatma F. Abdel Hamid, Reem Nabil

  • February 12, 2026

Related Content

Editorial: A new perspective on the importance of dendritic cells in cancer immunity: from bench to patient’s bedside

Combination of Lisaftoclax, Ixazomib, and Dexamethasone for Maintenance Therapy Following CAR-T in Patients with Transplant-Ineligible Relapsed/Refractory Ultra-High-Risk Multiple Myeloma: A Review of Two Cases and Relevant Literature

Understanding the Role of Regulatory T Cells in the Immune Microenvironment of Multiple Myeloma and Its Clinical Implications